FDA Working to Lift Barriers to Generic Drug Competition By Anna Jurczynska | June 28, 2017 Posted in Recent News and tagged commissioner, FDA, generic drugs, generic medicines, scott gottlieb, U.S. Food and Drug Administration ← New action plan to support SMEs as drivers of pharmaceutical innovationConcept paper on development and lifecycle of personalised medicines and companion diagnostics →